Halozyme Therapeutics Shares Down 45.6% Since SmarTrend's Sell Call (HALO)

SmarTrend identified a Downtrend for Halozyme Therapeutics (NASDAQ:HALO) on January 11th, 2016 at $13.39. In approximately 4 weeks, Halozyme Therapeutics has returned 45.61% as of today's recent price of...